Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00399711

Public ClinicalTrials.gov record NCT00399711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 7:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Repaglinide and Metformin Combination Tablet (NN4440) in a TID Regimen Compared to a BID Regimen and BID Avandamet in Subjects With Type 2 Diabetes: A Twenty-Six Week, Open-Label, Multicenter, Randomized, Parallel Group Trial to Investigate Efficacy and Safety

Study identification

NCT ID
NCT00399711
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
560 participants

Conditions and interventions

Interventions

  • repaglinide and metformin combination tablet Drug
  • rosiglitazone and metformin combination tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Oct 31, 2007
Completion
Oct 31, 2007
Last update posted
Feb 9, 2017

2006 – 2007

United States locations

U.S. sites
102
U.S. states
35
U.S. cities
93
Facility City State ZIP Site status
Novo Nordisk Investigational Site Vestavia Hills Alabama 35209
Novo Nordisk Investigational Site Glendale Arizona 85306
Novo Nordisk Investigational Site Mesa Arizona 85206
Novo Nordisk Investigational Site Jonesboro Arkansas 72401
Novo Nordisk Investigational Site Chula Vista California 91911
Novo Nordisk Investigational Site Long Beach California 90807
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Poway California 92064
Novo Nordisk Investigational Site Redlands California 92374
Novo Nordisk Investigational Site Sacramento California 95825
Novo Nordisk Investigational Site San Diego California 92121
Novo Nordisk Investigational Site San Diego California 92128
Novo Nordisk Investigational Site San Mateo California 94401
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Colorado Springs Colorado 80904
Novo Nordisk Investigational Site Hamden Connecticut 06518
Novo Nordisk Investigational Site Stamford Connecticut 06905
Novo Nordisk Investigational Site Aventura Florida 33180
Novo Nordisk Investigational Site Clearwater Florida 33765
Novo Nordisk Investigational Site Daytona Beach Florida 32117
Novo Nordisk Investigational Site Inverness Florida 34452
Novo Nordisk Investigational Site Jacksonville Florida 32116
Novo Nordisk Investigational Site Jacksonville Florida 32216
Novo Nordisk Investigational Site Jacksonville Florida 32259
Novo Nordisk Investigational Site Longwood Florida 32779
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Orlando Florida 32804
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site Tampa Florida 33603
Novo Nordisk Investigational Site West Palm Beach Florida 33401
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Columbus Georgia 31904
Novo Nordisk Investigational Site Marietta Georgia 30066
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Nampa Idaho 83687
Novo Nordisk Investigational Site Arlington Heights Illinois 60004
Novo Nordisk Investigational Site Aurora Illinois 60504
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Chicago Illinois 60611
Novo Nordisk Investigational Site Chicago Illinois 60616
Novo Nordisk Investigational Site Flossmoor Illinois 60422
Novo Nordisk Investigational Site Naperville Illinois 60564
Novo Nordisk Investigational Site Oak Brook Illinois 60523
Novo Nordisk Investigational Site Springfield Illinois 62711
Novo Nordisk Investigational Site Vernon Hills Illinois 60061
Novo Nordisk Investigational Site Indianapolis Indiana 46250
Novo Nordisk Investigational Site Des Moines Iowa 50314
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Erlanger Kentucky 41018
Novo Nordisk Investigational Site Louisville Kentucky 40213
Novo Nordisk Investigational Site Bossier City Louisiana 71111
Novo Nordisk Investigational Site Baltimore Maryland 21209
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Ann Arbor Michigan 48106
Novo Nordisk Investigational Site Flint Michigan 48504
Novo Nordisk Investigational Site Oak Park Michigan 48237
Novo Nordisk Investigational Site Troy Michigan 48098
Novo Nordisk Investigational Site Kansas City Missouri 64111
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Las Vegas Nevada 89102
Novo Nordisk Investigational Site Las Vegas Nevada 89123
Novo Nordisk Investigational Site Berlin New Jersey 08009
Novo Nordisk Investigational Site Jersey City New Jersey 07306
Novo Nordisk Investigational Site Warren Township New Jersey 07059
Novo Nordisk Investigational Site Rochester New York 14609
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Raleigh North Carolina 27609
Novo Nordisk Investigational Site Salisbury North Carolina 28144
Novo Nordisk Investigational Site Wilmington North Carolina 28401
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103
Novo Nordisk Investigational Site Cincinnati Ohio 45245
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Tulsa Oklahoma 74104
Novo Nordisk Investigational Site Tulsa Oklahoma 74136
Novo Nordisk Investigational Site Portland Oregon 97220
Novo Nordisk Investigational Site Norristown Pennsylvania 19401
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19152
Novo Nordisk Investigational Site Springfield Pennsylvania 19064-2527
Novo Nordisk Investigational Site Cranston Rhode Island 02920
Novo Nordisk Investigational Site East Providence Rhode Island 02914
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Mt. Pleasant South Carolina 29464
Novo Nordisk Investigational Site Simpsonville South Carolina 29681-1538
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Knoxville Tennessee 37920
Novo Nordisk Investigational Site Corpus Christi Texas 78412
Novo Nordisk Investigational Site Dallas Texas 75224
Novo Nordisk Investigational Site Dallas Texas 75390-8858
Novo Nordisk Investigational Site Houston Texas 77024
Novo Nordisk Investigational Site Houston Texas 77030
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site Plano Texas 75093
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site St. George Utah 84790
Novo Nordisk Investigational Site Henrico Virginia 23233
Novo Nordisk Investigational Site Lebanon Virginia 24266
Novo Nordisk Investigational Site Richmond Virginia 23229
Novo Nordisk Investigational Site Virginia Beach Virginia 23454
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00399711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2017 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00399711 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →